It acts on the opioid receptors of the intestinal wall, preventing the release of acetylcholine and prostaglandins, thereby inhibiting intestinal peristalsis and prolonging the retention time of intestinal contents. It can increase the tension of the anal sphincter, thereby inhibiting fecal incontinence and urgency, and can also be used for patients undergoing anorectal surgery. Its high affinity with the intestinal wall and obvious "first-pass metabolism" make it almost non-entering the systemic blood circulation.

1It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. 2This product exerts its pharmacological effects by inhibiting cyclooxygenase/a synthase to reduce the synthesis of local prostaglandins in tissues, inhibit the chemotaxis of leukocytes and the release of lysosomal enzymes. 3Acute toxicity test results: The oral LD50 of mice is 360mg/kg.

1It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. 2This product exerts its pharmacological effects by inhibiting cyclooxygenase/a synthase to reduce the synthesis of local prostaglandins in tissues, inhibit the chemotaxis of leukocytes and the release of lysosomal enzymes. 3Acute toxicity test results: The oral LD50 of mice is 360mg/kg.

1It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. 2This product exerts its pharmacological effects by inhibiting cyclooxygenase/a synthase to reduce the synthesis of local prostaglandins in tissues, inhibit the chemotaxis of leukocytes and the release of lysosomal enzymes. 3Acute toxicity test results: The oral LD50 of mice is 360mg/kg.

1It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. 2This product exerts its pharmacological effects by inhibiting cyclooxygenase/a synthase to reduce the synthesis of local prostaglandins in tissues, inhibit the chemotaxis of leukocytes and the release of lysosomal enzymes. 3Acute toxicity test results: The oral LD50 of mice is 360mg/kg.

1It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. 2This product exerts its pharmacological effects by inhibiting cyclooxygenase/a synthase to reduce the synthesis of local prostaglandins in tissues, inhibit the chemotaxis of leukocytes and the release of lysosomal enzymes. 3Acute toxicity test results: The oral LD50 of mice is 360mg/kg.

1It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. 2This product exerts its pharmacological effects by inhibiting cyclooxygenase/a synthase to reduce the synthesis of local prostaglandins in tissues, inhibit the chemotaxis of leukocytes and the release of lysosomal enzymes. 3Acute toxicity test results: The oral LD50 of mice is 360mg/kg.

1It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. 2This product exerts its pharmacological effects by inhibiting cyclooxygenase/a synthase to reduce the synthesis of local prostaglandins in tissues, inhibit the chemotaxis of leukocytes and the release of lysosomal enzymes. 3Acute toxicity test results: The oral LD50 of mice is 360mg/kg.

1It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. 2This product exerts its pharmacological effects by inhibiting cyclooxygenase/a synthase to reduce the synthesis of local prostaglandins in tissues, inhibit the chemotaxis of leukocytes and the release of lysosomal enzymes. 3Acute toxicity test results: The oral LD50 of mice is 360mg/kg.

1It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. 2This product exerts its pharmacological effects by inhibiting cyclooxygenase/a synthase to reduce the synthesis of local prostaglandins in tissues, inhibit the chemotaxis of leukocytes and the release of lysosomal enzymes. 3Acute toxicity test results: The oral LD50 of mice is 360mg/kg.

1It is a non-steroidal anti-inflammatory drug with analgesic, anti-inflammatory and antipyretic effects. 2This product exerts its pharmacological effects by inhibiting cyclooxygenase/a synthase to reduce the synthesis of local prostaglandins in tissues, inhibit the chemotaxis of leukocytes and the release of lysosomal enzymes. 3Acute toxicity test results: The oral LD50 of mice is 360mg/kg.

It is a local irritant that can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. It has a cooling effect on the mucosa; it can cause blood vessels to contract and reduce edema when used on inflamed mucosa.

The active ingredient of this product, menthol, is a local irritant. When used locally, it can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. When used on the mucosa, it has a cooling effect; when used on inflamed mucosa, it can cause blood vessels to contract and reduce edema.

The active ingredient of this product, menthol, is a local irritant. When used locally, it can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. When used on the mucosa, it has a cooling effect; when used on inflamed mucosa, it can cause blood vessels to contract and reduce edema.